Sophie Perrin-Ninkovic

Author

Bristol-Myers Squibb (Switzerland)

Also Known As

S. Perrin-Ninkovic, S.M. Perrin-Ninkovic, Sophie M Perrin-Ninkovic, Sophie M. Perrin-Ninkovic, Sophie Perrin-Ninkovic

Publications

239

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (Switzerland)

About

Sophie Perrin-Ninkovic is an author at Bristol-Myers Squibb (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	234
2	Biochemistry	4	4	188
3	Cell Biology	4	4	183
4	Natural Sciences	3	3	136
5	Chemical Biology	2	2	64

Sophie Perrin-Ninkovic

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115 Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin, Journal of Medicinal Chemistry Drug TargetKinase InhibitorsPharmacotherapyPharmaceutical ChemistryTumor Biology	2015	72
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: <i>In Vitro</i> and <i>In Vivo</i> Characterization Deborah S. Mortensen, Kimberly E. Fultz, Shuichan Xu, Molecular Cancer Therapeutics Cancer BiologyMtorc1 ComplexTumor BiologyMolecular PharmacologySignaling Pathway	2015	52
Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors Deborah S. Mortensen, Sophie Perrin-Ninkovic, Roy Harris, Bioorganic & Medicinal Chemistry Letters Sar ExplorationMedicinal ChemistryDrug TargetNovel SeriesBiochemistry	2011	32
Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223 Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin, Journal of Medicinal Chemistry Drug TargetKinase InhibitorsPharmacotherapyChemical BiologyPharmaceutical Chemistry	2015	32
Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase Deborah S. Mortensen, John Sapienza, Branden G.S. Lee, Bioorganic & Medicinal Chemistry Letters Signal TransductionSignaling PathwayMolecular PathwayMedicineReceptor Tyrosine Kinase	2013	27
Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors Garrick K. Packard, Patrick Papa, Jennifer R. Riggs, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryB-raf InhibitorsMedicineRational Drug Design	2011	19

Page 1